Advertisement
The new analytics tool from Decision Resources entitled PatientFinder:Dyslipidemia reveals that Massachusetts, Maine and Vermont have the highestpercentage of untreated people with dyslipidemia who also have prescription(Rx) drug coverage. This potential is currently not being realized due to lowtreatment rates in these states. Massachusetts ranks 27th, Maine ranks 36thand Vermont ranks 40th in the percentage of their prevalent population thatare currently receiving drug therapy for dyslipidemia. The result of thisunder-treatment is that significant opportunity remains for dyslipidemiamarket growth in each of these states. This type of information is invaluableto pharmaceutical companies who are challenged to pinpoint the areas ofgreatest need for their drugs.
Advertisement
Why Pharmaceutical Companies Need this Information
With the type of information included in PatientFinder, pharmaceuticalorganizations can identify the local markets that offer the greatestopportunity for their branded drug. Companies can identify markets that areunderserved and determine if they should increase direct-to-consumeradvertising, work with the local managed care organizations to increaseawareness of the disease and benefits of their drug or align salesrepresentatives to maximize market potential.
About PatientFinder
PatientFinder is the only healthcare analytics tool that assesses localmarkets for expansion opportunity by determining the number of insuredpatients in each territory who have the disease but are untreated.PatientFinder covers each of the 50 U.S. states and 318 U.S. metropolitanstatistical areas (MSAs) and provides:
-- Disease-specific prevalence numbers for each U.S. state and MSA
-- Examination of treatment rates for the disease population to createpercent treated and percent untreated estimates by state and MSA
-- Unique analysis of the untreated population examined through a filterof Rx benefit coverage. The end result is an estimate of how many patients areuntreated but can afford therapy within each territory-the true local measureof opportunity for pharmaceutical companies
About Decision Resources
Decision Resources (www.decisionresources.com) is a world leader in marketresearch publications, advisory services and consulting designed to helpclients shape strategy, allocate resources and master their chosen markets.Decision Resources is a Decision Resources, Inc. company.All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders. For more information, contact: Elizabeth Marshall Decision Resources 781-296-2563 [email protected]
SOURCE Decision Resources
